| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial intelligence in systematic literature reviews: a case for cautious optimism
|
Kharawala, Saifuddin
|
|
|
138 |
C |
p. 243-244
|
artikel
|
| 2 |
A systematic review that is ``rapid'' and ``living'': A specific answer to the COVID-19 pandemic
|
Negrini, Stefano
|
|
|
138 |
C |
p. 194-198
|
artikel
|
| 3 |
Authors should also report the support for judgment when applying AMSTAR 2
|
Franco, Juan Victor Ariel
|
|
|
138 |
C |
p. 240
|
artikel
|
| 4 |
Clinical practice guidelines in low and middle income countries: experiences from colombia
|
Cabra-Bautista, Ginna
|
|
|
138 |
C |
p. 232-233
|
artikel
|
| 5 |
Cluster randomized trials of individual-level interventions were at high risk of bias
|
Easter, Christina
|
|
|
138 |
C |
p. 49-59
|
artikel
|
| 6 |
“Comment on Khan: ‘Flawed use of post publication data fabrication tests’. Research misconduct tests: putting patients’ interests first”
|
Khan, Khalid Saeed
|
|
|
138 |
C |
p. 227
|
artikel
|
| 7 |
Consistency of ranking was evaluated as new measure for prediction model stability: longitudinal cohort study
|
Li, Yan
|
|
|
138 |
C |
p. 168-177
|
artikel
|
| 8 |
COVID-19 and the future of clinical epidemiology
|
Armstrong, Katrina
|
|
|
138 |
C |
p. 189-193
|
artikel
|
| 9 |
Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines
|
Wiercioch, Wojtek
|
|
|
138 |
C |
p. 115-127
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
138 |
C |
p. IFC
|
artikel
|
| 11 |
Editors’ Choice: October 2021
|
|
|
|
138 |
C |
p. A5
|
artikel
|
| 12 |
Ethics of COVID-19 vaccine trials in rapidly changing contexts
|
Knottnerus, J. André
|
|
|
138 |
C |
p. 213-214
|
artikel
|
| 13 |
Evaluating tests for diagnosing COVID-19 in the absence of a reliable reference standard: pitfalls and potential solutions
|
Korevaar, Daniël A.
|
|
|
138 |
C |
p. 182-188
|
artikel
|
| 14 |
“Evidence-based checklists” for identifying predatory journals have not been assessed for reliability or validity: An analysis and proposal for moving forward
|
Ng, Jeremy Y.
|
|
|
138 |
C |
p. 40-48
|
artikel
|
| 15 |
Favouring imperfect awareness over perfect ignorance
|
Nguyen, T.L.
|
|
|
138 |
C |
p. 238-239
|
artikel
|
| 16 |
High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study
|
Mouffak, Amelle
|
|
|
138 |
C |
p. 73-79
|
artikel
|
| 17 |
Informing the GRADE evidence to decision process with health equity considerations: demonstration from the Canadian rheumatoid arthritis care context
|
Barnabe, Cheryl
|
|
|
138 |
C |
p. 147-155
|
artikel
|
| 18 |
Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination
|
Venema, Esmee
|
|
|
138 |
C |
p. 32-39
|
artikel
|
| 19 |
Letter to the Editor - Methodological quality was critically low in 9/10 systematic reviews in advanced cancer patients—A methodological study
|
Peters, Micah DJ
|
|
|
138 |
C |
p. 234
|
artikel
|
| 20 |
Letter to the Editor on detecting and dealing with heterogeneity in meta-analyses by Cordero and Dans.
|
Hoaglin, David C.
|
|
|
138 |
C |
p. 230
|
artikel
|
| 21 |
Letter to the editor regarding "Incomparability of treatment groups is often blindly ignored in randomised controlled trials – a post hoc analysis of baseline characteristic tables"
|
Knight, Ruth
|
|
|
138 |
C |
p. 237
|
artikel
|
| 22 |
Methodology over metrics: current scientific standards are a disservice to patients and society
|
Van Calster, Ben
|
|
|
138 |
C |
p. 219-226
|
artikel
|
| 23 |
Nearly 80 systematic reviews were published each day: Observational study on trends in epidemiology and reporting over the years 2000-2019
|
Hoffmann, Falk
|
|
|
138 |
C |
p. 1-11
|
artikel
|
| 24 |
Noncollapsibility, confounding, and sparse-data bias. Part 1: The oddities of odds
|
Greenland, Sander
|
|
|
138 |
C |
p. 178-181
|
artikel
|
| 25 |
Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study
|
Mostazir, Mohammod
|
|
|
138 |
C |
p. 12-21
|
artikel
|
| 26 |
Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty
|
Chan, Claire L
|
|
|
138 |
C |
p. 102-114
|
artikel
|
| 27 |
Placebo-controlled trials with COVID-19 vaccines: participants first
|
Dal-Ré, Rafael
|
|
|
138 |
C |
p. 211-212
|
artikel
|
| 28 |
Prespecification of subgroup analyses and examination of treatment-subgroup interactions in cancer individual participant data meta-analyses are suboptimal
|
Gao, Ya
|
|
|
138 |
C |
p. 156-167
|
artikel
|
| 29 |
Quality of clinical practice guidelines in Japan remains low: A cross-sectional meta-epidemiological study
|
Kataoka, Yuki
|
|
|
138 |
C |
p. 22-31
|
artikel
|
| 30 |
Randomized COVID-19 vaccination rollout can offer direct real-world evidence
|
Hemkens, Lars G.
|
|
|
138 |
C |
p. 199-202
|
artikel
|
| 31 |
Reconciling contrasting guideline recommendations on red and processed meat for health outcomes
|
Vernooij, RWM
|
|
|
138 |
C |
p. 215-218
|
artikel
|
| 32 |
Reply to letter to the editor by Franco et al. AMSTAR 2 overall confidence rating: A call for even more transparency
|
Lorenz, Robert C.
|
|
|
138 |
C |
p. 241-242
|
artikel
|
| 33 |
Reply to letter to the editor by Kharawala S, et al: Artificial intelligence for assisting systematic reviews: Opportunities with continuing challenges
|
Qin, Xuan
|
|
|
138 |
C |
p. 245-246
|
artikel
|
| 34 |
Reply to letter to the editor by Peters: knowledge transfer is the key
|
Siemens, W.
|
|
|
138 |
C |
p. 235-236
|
artikel
|
| 35 |
Reply to the Letter to the Editor from David C. Hoaglin regarding the article by Cynthia P. Cordero and Antonio L. Dans entitled “Key concepts in clinical epidemiology: Detecting and dealing with heterogeneity in meta-analyses” [1]
|
Cordero, Cynthia P.
|
|
|
138 |
C |
p. 231
|
artikel
|
| 36 |
Reporting of prognostic clinical prediction models based on machine learning methods in oncology needs to be improved
|
Dhiman, Paula
|
|
|
138 |
C |
p. 60-72
|
artikel
|
| 37 |
Research misconduct tests: putting patients’ interests first
|
van Wely, Madelon
|
|
|
138 |
C |
p. 228-229
|
artikel
|
| 38 |
Study designs for comparative diagnostic test accuracy: A methodological review and classification scheme
|
Yang, Bada
|
|
|
138 |
C |
p. 128-138
|
artikel
|
| 39 |
Systematic review automation tools improve efficiency but lack of knowledge impedes their adoption: a survey
|
Scott, Anna Mae
|
|
|
138 |
C |
p. 80-94
|
artikel
|
| 40 |
Table of Contents
|
|
|
|
138 |
C |
p. A2-A4
|
artikel
|
| 41 |
The impact of gender on researchers’ assessment: A randomized controlled trial
|
Franco, Marina Christ
|
|
|
138 |
C |
p. 95-101
|
artikel
|
| 42 |
The possible effects of iron loss from bloodletting on mortality from pneumonia in the nineteenth century
|
Brabin, Bernard
|
|
|
138 |
C |
p. 139-146
|
artikel
|
| 43 |
Using preprints in evidence synthesis: Commentary on experience during the COVID-19 pandemic
|
Clyne, Barbara
|
|
|
138 |
C |
p. 203-210
|
artikel
|
Tijdschrift beschrijving